Pharmacy Market BUZZ

Market News, Products, Services, and Trends

Reliable, rapid PCR test for the detection of SARS-CoV-2 in 30 minutes

The Thermo Fisher Scientific Accula™ System is a rapid diagnostic platform that combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula™ SARS-CoV-2 Test has received an Emergency Use Authorization (EUA) from the FDA for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA)–waived environments. Designed for use with the palm-sized Accula™ Dock, the Accula SARS-CoV-2 Test provides reliable, qualitative results in approximately 30 minutes. 

The Accula SARS-CoV-2 Test and Accula Dock Feature:

• Accurate PCR technology—100% positive agreement (PPA) and negative agreement (NPA) with an EUA-authorized RT-PCR SARS-CoV-2 test comparator 

• Simple sample collection—prepare and load nasal swab samples in seconds

• Fast results—qualitative, rapid PCR-based test provides visual results in 30 minutes

• Easy storage—reagents stored at room temperature (15°C–30°C, 59°F–86°F); eluted samples in Accula™ buffer may be kept at room temperature for up to 2 hours or refrigerated at 2°C–8°C and tested within 24 hours from the time of elution

• Compact design—dock fits in the palm of your hand; ideal fit for satellite locations and clinical settings

Learn More

Today's Posts